Sonora Investment Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Sonora Investment Management Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$281K	Hold	500	–	–	0.02%	231
2025 Q2	$263K	Hold	500	–	–	0.02%	234
2025 Q1	$317K	Hold	500	–	–	0.03%	216
2024 Q4	$356K	Hold	500	–	–	0.03%	199
2024 Q3	$526K	Hold	500	–	–	0.04%	170
2024 Q2	$481K	Hold	500	–	–	0.04%	178
2024 Q1	$481K	Hold	500	–	–	0.04%	178
2023 Q4	$439K	Hold	500	–	–	0.04%	175
2023 Q3	$411K	Hold	500	–	–	0.04%	175
2023 Q2	$359K	Hold	500	–	–	0.03%	190
2023 Q1	$411K	Sell	500 -1	-0.2%	-$754	0.04%	174
2022 Q4	$361K	Buy	+501	New	+$370K	0.03%	185

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sonora Investment Management Group's REGN Position: Q3 2025 in Review

Sonora Investment Management Group held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2025 at 500 shares worth $281K. The position accounts for 0.02% of the portfolio, ranked #231.

Sonora Investment Management Group first reported a position in REGN in Q4 2022 and has held it in 12 quarters since. The position peaked at $526K in Q3 2024. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Sonora Investment Management Group held 500 shares of Regeneron Pharmaceuticals worth $281K as of Q3 2025.
Sonora Investment Management Group left its Regeneron Pharmaceuticals share count unchanged in Q3 2025.
Regeneron Pharmaceuticals made up 0.02% of Sonora Investment Management Group's portfolio in Q3 2025, its #231 holding.
Sonora Investment Management Group first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
Sonora Investment Management Group's Regeneron Pharmaceuticals position peaked at $526K in Q3 2024.
1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.